DE2237832A1 - Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin - Google Patents

Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin

Info

Publication number
DE2237832A1
DE2237832A1 DE2237832A DE2237832A DE2237832A1 DE 2237832 A1 DE2237832 A1 DE 2237832A1 DE 2237832 A DE2237832 A DE 2237832A DE 2237832 A DE2237832 A DE 2237832A DE 2237832 A1 DE2237832 A1 DE 2237832A1
Authority
DE
Germany
Prior art keywords
compound
thrombosis
formula
atherosclerosis
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2237832A
Other languages
German (de)
English (en)
Inventor
Michiro Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2237832A1 publication Critical patent/DE2237832A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
DE2237832A 1971-08-05 1972-08-01 Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin Pending DE2237832A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP46058643A JPS5116430B2 (es) 1971-08-05 1971-08-05

Publications (1)

Publication Number Publication Date
DE2237832A1 true DE2237832A1 (de) 1973-02-15

Family

ID=13090247

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2237832A Pending DE2237832A1 (de) 1971-08-05 1972-08-01 Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin
DE2238566A Pending DE2238566A1 (de) 1971-08-05 1972-08-04 Neue phthalazonderivate und verfahren zu deren herstellung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE2238566A Pending DE2238566A1 (de) 1971-08-05 1972-08-04 Neue phthalazonderivate und verfahren zu deren herstellung

Country Status (23)

Country Link
US (1) US3864343A (es)
JP (1) JPS5116430B2 (es)
AR (3) AR194123A1 (es)
AT (2) AT320658B (es)
AU (2) AU461281B2 (es)
BE (2) BE787138A (es)
CA (2) CA966489A (es)
CH (2) CH580081A5 (es)
CS (2) CS180587B2 (es)
DE (2) DE2237832A1 (es)
DK (2) DK131857C (es)
ES (2) ES405456A1 (es)
FR (2) FR2150735B1 (es)
GB (2) GB1404367A (es)
HU (2) HU165815B (es)
IE (2) IE36597B1 (es)
LU (2) LU65856A1 (es)
NL (2) NL7210369A (es)
NO (1) NO134113C (es)
SE (2) SE408177B (es)
SU (2) SU577986A3 (es)
YU (1) YU35245B (es)
ZA (2) ZA725202B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
NL7702763A (nl) * 1976-03-18 1977-09-20 Takio Shimamoto En Masayuki Is Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4293553A (en) * 1978-08-11 1981-10-06 Masayuki Ishikawa 1-Phthalazone derivatives, and use thereof
US4861778A (en) * 1986-06-16 1989-08-29 Research Corporation 2,3-dihydrophthalazine-1,4-diones
CH683965A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
DE102005011822A1 (de) * 2005-03-15 2006-09-21 Merck Patent Gmbh Phthalazinone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE687916A (es) * 1965-10-12 1967-03-16

Also Published As

Publication number Publication date
BE787139A (fr) 1972-12-01
DK131857C (da) 1976-02-16
DE2238566A1 (de) 1973-02-15
AT317233B (de) 1974-08-26
CA966489A (en) 1975-04-22
SE408177B (sv) 1979-05-21
AU4494072A (en) 1974-01-31
YU35245B (en) 1980-10-31
CA999236A (en) 1976-11-02
IE36598B1 (en) 1976-12-08
YU201372A (en) 1980-04-30
CS180588B2 (en) 1978-01-31
CH577980A5 (es) 1976-07-30
GB1404368A (en) 1975-08-28
JPS4826781A (es) 1973-04-09
GB1404367A (en) 1975-08-28
AT320658B (de) 1975-02-25
DK131857B (da) 1975-09-15
HU163726B (es) 1973-10-27
ZA725202B (en) 1973-04-25
BE787138A (fr) 1972-12-01
DK143159C (da) 1981-11-16
ES405555A1 (es) 1975-07-01
ZA725203B (en) 1973-04-25
CS180587B2 (en) 1978-01-31
SU577986A3 (ru) 1977-10-25
FR2150736B1 (es) 1976-04-16
ES405456A1 (es) 1975-07-16
AU461018B2 (en) 1975-05-15
NO134113C (es) 1976-08-18
AR194123A1 (es) 1973-06-22
DK143159B (da) 1981-07-06
CH580081A5 (es) 1976-09-30
SU513622A3 (ru) 1976-05-05
NL7210369A (es) 1973-02-07
IE36598L (en) 1973-02-05
FR2150735B1 (es) 1976-04-16
AR197089A1 (es) 1974-03-15
AU461281B2 (en) 1975-05-22
IE36597B1 (en) 1976-12-08
JPS5116430B2 (es) 1976-05-24
FR2150735A1 (es) 1973-04-13
AR197156A1 (es) 1974-03-15
HU165815B (es) 1974-11-28
AU4484372A (en) 1974-01-24
NO134113B (es) 1976-05-10
US3864343A (en) 1975-02-04
LU65856A1 (es) 1973-01-15
IE36597L (en) 1973-02-05
NL7210370A (es) 1973-02-07
LU65855A1 (es) 1973-01-15
NL151261B (nl) 1976-11-15
SE406587B (sv) 1979-02-19
FR2150736A1 (es) 1973-04-13

Similar Documents

Publication Publication Date Title
DE2637110C3 (de) Heteroarylbenzoxepin-essigsäuren und deren Ester, Verfahren zu ihrer Herstellung und deren Verwendung
DE2721171A1 (de) Neues vincaminsalz, seine herstellung und es enthaltende pharmazeutische zubereitungen
DE1801750C3 (de) Prostaglandin-E-Carbinole und deren Tricarbonsäureester
EP0010156B1 (de) 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2237832A1 (de) Verfahren zur herstellung von 4hydroxymethyl-1-keto-1,2-dihydrophthalazin
DE2745598A1 (de) Arylschwefelverbindungen, verfahren zu ihrer herstellung und sie enthaltendes pharmazeutisches mittel
DE2156499A1 (de) N-substituierte 2-Carboxy-l-azacyclische Verbindungen
DE2431561C2 (de) Cycloalkylphenoxycarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel
DE2818351A1 (de) Benzoesaeurederivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE2038836C3 (de) Arzneimittel
DE1947226C3 (de) 1 l-Chlor-8,12b-dihydro-23-dimethyll2b-phenyl-4H [13] -oxazino [3,2-d] [1,4] benzodiazepin-4,7(6H)dion und Verfahren zur Herstellung dieser Verbindung
DE2329815C3 (de) Pharmazeutisches Mittel zur Behandlung von Atherosklerose, Thrombose und Hämorrhagie
DE1934392B2 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
DE2235406B2 (de) 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE3028927A1 (de) Mittel, welche azoverbindungen enthalten
AT337709B (de) Verfahren zur herstellung von neuen 1-phthalazonderivaten
AT339911B (de) Verfahren zur herstellung eines neuen 1-phthalazonderivates
DE1695605A1 (de) Verfahren zur Herstellung von Chinoxalin-N,N'-dioxyden
DE2104995B2 (de) Halogenierte Benzylphenole, deren Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2113489B2 (de) 2-Nitro-benzofuranderivate, ein Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
AT238218B (de) Verfahren zur Herstellung von neuen Benzolsulfonyl-semicarbaziden
AT336617B (de) Verfahren zur herstellung von neuen heterocyclischen verbindungen
DE1543744C3 (de) 3-Alkylflavanone und Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1912063A1 (de) 3-Amino-1,2,3,4-tetrahydrofluorene und Verfahren zu ihrer Herstellung
DE1795782C3 (de) N-Trityl-imidazole